ipilimumab,nivolumab
bms
['ipilimumab', 'nivolumab', 'nivo', 'opacin-neo', 'melanoma']
at #asco22 #melanoma and skin cancer session? check out the results of the prado extension cohort of the opacin-neo trial on personalized treatment after neoadjuvant ipilimumab + nivolumab in melanoma, led by speaker published today 
Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.